Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma

NCT00813449 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Advanced Melanoma
Untreated Patients

Interventions

DRUG: dacarbazine plus Endostar (Experimental group)
DRUG: dacarbazine plus placebo (control group)

Sponsor

Simcere Pharmaceutical Co., Ltd